RhumbLine Advisers’s Alnylam Pharmaceuticals ALNY Stock Holding History

RhumbLine Advisers’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$64.6M	Buy	195,277 +11	+0%	+$3.74K	0.06%	291
2025 Q4	$77.6M	Sell	195,266 -1,231	-0.6%	-$545K	0.06%	247
2025 Q3	$89.6M	Sell	196,497 -3,988	-2%	-$1.62M	0.07%	224
2025 Q2	$65.4M	Buy	200,485 +19,022	+10%	+$5.26M	0.06%	276
2025 Q1	$49M	Buy	181,463 +1,885	+1%	+$484K	0.05%	342
2024 Q4	$42.3M	Sell	179,578 -1,850	-1%	-$487K	0.04%	390
2024 Q3	$49.9M	Buy	181,428 +8,101	+5%	+$2.11M	0.05%	340
2024 Q2	$42.1M	Sell	173,327 -362	-0.2%	-$57.2K	0.04%	369
2024 Q1	$26M	Buy	173,689 +816	+0.5%	+$136K	0.02%	565
2023 Q4	$33.1M	Buy	172,873 +802	+0.5%	+$137K	0.03%	439
2023 Q3	$30.5M	Sell	172,071 -3,263	-2%	-$623K	0.04%	440
2023 Q2	$33.3M	Buy	175,334 +17,439	+11%	+$3.46M	0.04%	422
2023 Q1	$31.6M	Buy	157,895 +9,499	+6%	+$2M	0.04%	416
2022 Q4	$35.3M	Buy	148,396 +11,711	+9%	+$2.5M	0.05%	363
2022 Q3	$27.4M	Buy	136,685 +8,174	+6%	+$1.56M	0.04%	411
2022 Q2	$18.7M	Buy	128,511 +12,634	+11%	+$1.79M	0.03%	571
2022 Q1	$18.9M	Sell	115,877 -3,955	-3%	-$603K	0.02%	609
2021 Q4	$20.3M	Buy	119,832 +3,723	+3%	+$692K	0.02%	613
2021 Q3	$21.9M	Sell	116,109 -306	-0.3%	-$57.4K	0.03%	535
2021 Q2	$19.7M	Sell	116,415 -5,608	-5%	-$821K	0.03%	606
2021 Q1	$17.2M	Sell	122,023 -4,549	-4%	-$685K	0.02%	668
2020 Q4	$16.5M	Sell	126,572 -7,326	-5%	-$978K	0.02%	638
2020 Q3	$19.5M	Sell	133,898 -6,577	-5%	-$935K	0.03%	480
2020 Q2	$20.8M	Buy	140,475 +28,498	+25%	+$3.84M	0.03%	436
2020 Q1	$12.2M	Buy	111,977 +5,872	+6%	+$678K	0.03%	574
2019 Q4	$12.2M	Buy	106,105 +3,059	+3%	+$305K	0.02%	720
2019 Q3	$8.29M	Sell	103,046 -9	-0%	-$712	0.02%	884
2019 Q2	$7.48M	Buy	103,055 +10,164	+11%	+$780K	0.01%	952
2019 Q1	$8.68M	Buy	92,891 +2,295	+3%	+$192K	0.02%	838
2018 Q4	$6.61M	Sell	90,596 -5,849	-6%	-$450K	0.01%	934
2018 Q3	$8.44M	Sell	96,445 -1,501	-2%	-$151K	0.02%	773
2018 Q2	$9.65M	Buy	97,946 +2,591	+3%	+$257K	0.02%	701
2018 Q1	$11.4M	Sell	95,355 -4,560	-5%	-$588K	0.02%	613
2017 Q4	$12.7M	Buy	99,915 +7,347	+8%	+$923K	0.03%	588
2017 Q3	$10.9M	Buy	92,568 +1,346	+1%	+$115K	0.02%	623
2017 Q2	$7.28M	Sell	91,222 -3,189	-3%	-$204K	0.02%	799
2017 Q1	$4.84M	Buy	94,411 +4,028	+4%	+$186K	0.01%	1021
2016 Q4	$3.38M	Buy	90,383 +7,712	+9%	+$323K	0.01%	1143
2016 Q3	$5.6M	Buy	82,671 +2,407	+3%	+$170K	0.02%	824
2016 Q2	$4.45M	Buy	80,264 +4,740	+6%	+$299K	0.01%	872
2016 Q1	$4.74M	Sell	75,524 -150	-0.2%	-$9.97K	0.01%	860
2015 Q4	$7.12M	Buy	75,674 +2,053	+3%	+$190K	0.02%	652
2015 Q3	$5.92M	Buy	73,621 +3,281	+5%	+$365K	0.02%	728
2015 Q2	$8.43M	Buy	70,340 +11,510	+20%	+$1.38M	0.03%	590
2015 Q1	$6.14M	Buy	58,830 +5,081	+9%	+$515K	0.02%	738
2014 Q4	$5.21M	Sell	53,749 -131	-0.2%	-$12.1K	0.02%	775
2014 Q3	$4.21M	Sell	53,880 -308	-0.6%	-$19.9K	0.01%	856
2014 Q2	$3.42M	Sell	54,188 -8,952	-14%	-$532K	0.01%	1019
2014 Q1	$4.24M	Sell	63,140 -2,860	-4%	-$221K	0.01%	909
2013 Q4	$4.25M	Buy	66,000 +2,140	+3%	+$128K	0.01%	911
2013 Q3	$4.09M	Buy	63,860 +679	+1%	+$33.8K	0.01%	913
2013 Q2	$1.96M	Buy	+63,181	New	+$1.68M	0.01%	1314